1. Understanding the role of Cripto-1 in cancer progression and therapeutic strategies

   • Qingfang Zeng
   • Yuzhen Gao
   • Ying Zhou

   REVIEW ARTICLE 01 December 2022 Pages: 1135 - 1144

   

2. Cancer secretome: finding out hidden messages in extracellular secretions

   • Mrunali Padgaonkar
   • Saket Shendre
   • Satarupa Banerjee

   REVIEW ARTICLE 16 December 2022 Pages: 1145 - 1155

   

3. CRISPR-Cas9-mediated gene therapy in lung cancer

   • Hossein Kazemizadeh
   • Alireza Kashefizadeh

   REVIEW ARTICLE 10 December 2022 Pages: 1156 - 1166

   

4. siRNA and targeted delivery systems in breast cancer therapy

   • Sepideh Mirzaei
   • Mahshid Deldar Abad Paskeh
   • Saeed Samarghandian

   REVIEW ARTICLE 23 December 2022 Pages: 1167 - 1188

   

5. MicroRNA-452: a double-edged sword in multiple human cancers

   • Fateme Karimi Dermani
   • Ishwaree Datta
   • Saeideh Gholamzadeh Khoei

   REVIEW ARTICLE 09 January 2023 Pages: 1189 - 1206

   

6. The multifaced role and therapeutic regulation of autophagy in ovarian cancer

   • Fahimeh Nokhostin
   • Mahboobeh Azadehrah
   • Malihe Azadehrah

   REVIEW ARTICLE 19 December 2022 Pages: 1207 - 1217

   

7. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies

   • Yogita Chhichholiya
   • Malayil Ruthuparna
   • Anjana Munshi

   REVIEW ARTICLE 10 March 2023 Pages: 1218 - 1241

   

8. PARs in the inflammation-cancer transformation of CRC

   • Jianyu Lv
   • Jinguo Liu
   • Shuo Zhang

   REVIEW ARTICLE 22 December 2022 Pages: 1242 - 1251

   

9. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

   • Dolores Isla
   • Maria D. Lozano
   • Ana Belén Enguita

   SPECIAL ARTICLE Open access 26 December 2022 Pages: 1252 - 1267

   

10. Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution

    • Felipe A. Calvo
    • Jacobo Palma
    • Javier Aristu

    SPECIAL ARTICLE Open access 24 March 2023 Pages: 1268 - 1276

    

11. C-Fos-activated circRPPH1 contributes to glioma stemness

    • Gang Xu
    • Jianqiang Qu
    • Qian Wang

    RESEARCH ARTICLE 01 December 2022 Pages: 1277 - 1286

    

12. Radiation pneumonitis in relation to pulmonary function, dosimetric factors, TGFβ1 expression, and quality of life in breast cancer patients receiving post-operative radiotherapy: a prospective 6-month follow-up study

    • Zerrin Ozgen
    • Oya Orun
    • Sait Karakurt

    RESEARCH ARTICLE 08 December 2022 Pages: 1287 - 1296

    

13. ¹²⁵I brachytherapy: a useful treatment to control painful osteoblastic bone metastases

    • Yiming Liu
    • Chengzhi Zhang
    • Dechao Jiao

    RESEARCH ARTICLE Open access 06 December 2022 Pages: 1297 - 1306

    

14. Risk and prognosis of secondary breast cancer after radiation therapy for non-Hodgkin lymphoma: a massive population-based analysis

    • Xiaoyan Lv
    • Pengpeng Yue
    • Fuling Zhou

    RESEARCH ARTICLE 07 December 2022 Pages: 1307 - 1314

    

15. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature

    • Yaqi Li
    • Xu Chen
    • Qingmin Sun

    RESEARCH ARTICLE 15 December 2022 Pages: 1315 - 1331

    

16. TIPE1 inhibits the growth of Ewing’s sarcoma cells by suppressing Wnt/β-catenin signaling

    • Zhichao Wang
    • Libin Sun
    • Haitao Jiang

    RESEARCH ARTICLE 10 December 2022 Pages: 1332 - 1339

    

17. High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer

    • Pei-yuan Qiu
    • Xi-han Deng
    • Li Li

    RESEARCH ARTICLE 17 December 2022 Pages: 1340 - 1352

    

18. Immune infiltration could predict the efficacy of short-term radiotherapy in patients with cervical cancer

    • Zhiqiang Sun
    • Xue Liu
    • Judong Luo

    RESEARCH ARTICLE 12 December 2022 Pages: 1353 - 1367

    

19. Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma

    • Orla A. Houlihan
    • Georgios Ntentas
    • Frances K. Duane

    RESEARCH ARTICLE Open access 31 December 2022 Pages: 1368 - 1377

    

20. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability

    • Chaojie Bu
    • Sen Hu
    • Xingyao Bu

    RESEARCH ARTICLE 09 December 2022 Pages: 1378 - 1388

    

21. Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming

    • Maurice Zaoui
    • Mehdi Morel
    • Michèle Sabbah

    RESEARCH ARTICLE 15 December 2022 Pages: 1389 - 1401

    

22. PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis

    • Jianguo Wang
    • Shizhong Cai
    • Zhourui Ma

    RESEARCH ARTICLE 17 December 2022 Pages: 1402 - 1412

    

23. Construction of prediction model for prognosis of uterine corpus endometrial carcinoma based on pyroptosis gene

    • Chunyan Zhang
    • Jie Bai
    • Lei Shao

    RESEARCH ARTICLE 15 December 2022 Pages: 1413 - 1424

    

24. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer

    • Runchang Wang
    • Dongyang Gao
    • Zhiping Wang

    RESEARCH ARTICLE 13 December 2022 Pages: 1425 - 1435

    

25. Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in gastric cancer: a systematic review and meta-analysis

    • Juan Ren
    • Qinglian He
    • Xiaoling Wu

    RESEARCH ARTICLE 18 December 2022 Pages: 1436 - 1445

    

26. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

    • Eduardo Ramos Elbal
    • José Luis Fuster
    • Alfredo Minguela

    RESEARCH ARTICLE 04 January 2023 Pages: 1446 - 1454

    

27. Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community

    • Mireia Gil Raga
    • Irene Paredero Pérez
    • Isabel Busquier Hernández

    RESEARCH ARTICLE 01 February 2023 Pages: 1455 - 1462

    

28. Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain

    • Paula Munoz
    • Sara Corral
    • Sonia Rivas

    RESEARCH ARTICLE 31 December 2022 Pages: 1463 - 1471

    

29. HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription

    • Jian Zhan
    • Qian Zhang
    • Chunbo Zhao

    RESEARCH ARTICLE 06 January 2023 Pages: 1472 - 1481

    

30. A multi-center cross-sectional investigation of the diagnosis and treatment of breast cancer with synchronous ipsilateral supraclavicular lymph node metastases based on the CSBrs-009

    • Xiang Ai
    • Peng Sun
    • Jun Jiang

    RESEARCH ARTICLE 07 January 2023 Pages: 1482 - 1487

31. Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    • Dolores Isla
    • Maria D. Lozano
    • Ana Belén Enguita

    Correction Open access 08 February 2023 Pages: 1488 - 1488